493 - 504 of 7633 results
Upset young man looking outside window with hand against window
0.5 CME CREDIT

What PCPs Should Know About Adjunctive Therapy for MDD (Module 3)

An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.50 AANP | 0.32 Pharmacology

This video-based resource activity is designed to provide an overview of adjunctive therapy to treat patients with MDD who are experiencing a partial treatment response. These therapies include second-generation antipsychotic agents, esketamine, and non-pharmacologic modalities. Expert faculty will discuss the neurochemical rationale behind adjunctive treatment and differentiate between the various pharmacologic agents, with an emphasis on efficacy, adverse effects, and clinical profiles that can guide their use.


Young lady holding her face down, really upset
0.5 CME CREDIT

MDD With a Partial Treatment Response—Candidates for Treatment Escalation (Module 1)

An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.46 AANP

This video-based resource activity will feature a dialogue between two expert faculty on the health, psychosocial, and functional burden of MDD on patients who experience an incomplete response to treatment. The discussion will emphasize the importance of prompt recognition of these individuals so that therapy advancement can occur at the earliest opportunity and will provide practical tools to help PCPs make this identification.


Two doctors talking/doctor explaining something to another doctor
0.25 CME CREDIT

Breaking It Down: COPD Treatments and Guidelines

An Interactive Video Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.25 CME/MOC
0.25 AANP | 0.25 Pharmacology

To disseminate applicable practice applications, a comprehensive infographic will be created. The infographic will focus on the different classes of treatment options for patients with COPD and considerations for individualized treatment selection based on guidance for ERS, ATS, and GOLD guidelines; including when to select combination therapy.


Speaker on virtual set
2 CME CREDITS

Migraine: A Patient-centered Approach to Diagnosis and Treatment

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

2.00 CME

How does your management of patients with migraine compare to the experts? By participating in this six-part educational initiative, which incorporates a comprehensive roundtable faculty discussion, augmented reality, and a patient narrative, you will be able to incorporate key information into your clinical practice immediately.


Doctor talking to a patient with an inhaler
0.25 CME CREDIT

Strategies for Assessing and Preventing Exacerbations: It May Not Be What You Thought

An Interactive Video Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.25 CME/MOC
0.25 AANP


Clinician reading or researching (as if reading up on dual vs triple inhaler therapy)
0.31 CME CREDIT

Individualized COPD Treatment Options: Keeping it Personal

An Interactive Video Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.25 CME/MOC
0.31 AANP | 0.31 Pharmacology


Upset young lady looking outside window on a rainy day
0.5 CME CREDIT

Advancing Antidepressant Therapy for Patients with MDD Who Have an Inadequate Treatment Response (Module 2)

An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.50 AANP | 0.25 Pharmacology

In this video-based resource activity, expert faculty will discuss options for advancing antidepressant therapy in patients with an incomplete response to antidepressant monotherapy, including the neurochemical rationale for combining antidepressant therapy. It will also provide an approach for selecting antidepressant therapy in which the drugs’ clinical profiles correspond best to individual patient’s symptoms and other clinical factors.


1 CME CREDIT

Axial spondyloarthritis/ankylosing spondylitis (axSpA/AS) imparts a significant burden on patients and caretakers. It negatively affects not only patient well-being and quality of life but also productivity during the prime of patients’ working lives. PCPs at the frontlines of care for patients with back pain are ideally positioned to identify individuals who may be suffering from axSpA/AS. Identification relies on a thorough understanding of the disease and its characteristics in addition to a high index of suspicion. This education will help PCPs to shorten the delay between symptom presentation and diagnosis and to improve rates of referral to rheumatology for diagnostic evaluation and confirmation.


2D image of getting over the cliff
0.25 CME CREDIT

Cases in Practice: Optimal Management of Adult Growth Hormone Deficiency Across the Spectrum, From Transitions in Care to Recent Treatment Advances (Module 4)

An Interactive Learning Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.25 CME/MOC
0.25 CE | 0.17 Pharmacology

You play a critical role in transitioning adolescent GHD patients to adult care and improving aGHD outcomes. Learn how to successfully manage this condition.


1 CME CREDIT

Addressing the Needs of Patients with Vasomotor Symptoms of Menopause: Current and Future Approaches

An Interactive Video Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

1.00 CME/MOC
1.00 AANP | 0.75 Pharmacology

Hot flashes and night sweats affect most women during the menopause transition and last for 7 to 10 years, on average. Despite the availability of both hormonal and nonhormonal therapies, most women receive no treatment at all. In this activity, expert faculty will review novel nonhormonal treatments in development as well as a range of available treatment options.


2D image of getting over the cliff
0.31 CME CREDIT

Current Concepts in Diagnosis of aGHD (Module 2)

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.25 CME/MOC
0.31 CE

You play a critical role in identifying patients who may benefit from aGHD testing. Learn how to assess the need for testing and interpret test results.


Senior man swallowing pill
0.5 CME CREDIT

What PCPs Need to Know About Influenza Treatment (Module 2)

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.40 AANP | 0.20 Pharmacology

In recent years, a new first-in-class antiviral emerged that expanded the arsenal of effective treatments for influenza. But do you know when to prescribe these therapies and which ones are most appropriate for each individual patient? Research has shown that only a fraction of patients at severe risk for influenza-related complications receive an antiviral medication within the appropriate timeframe of symptom onset. Before you see your next patient with influenza, you need to participate in this short and innovative video-based activity that is designed to enhance learning and keep you engaged. You will walk away with guideline-recommended strategies to appropriately initiate antiviral treatment for known or suspected influenza.